{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["29(3)"],"submitter":["Korean Association for the Study of the Liver (KASL)"],"journal":["Clinical and molecular hepatology"],"pagination":["542-592"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10366804"],"repository":["biostudies-literature"],"pubmed_title":["KASL clinical practice guidelines for management of autoimmune hepatitis 2022."],"pmcid":["PMC10366804"],"pubmed_authors":["Korean Association for the Study of the Liver (KASL)"],"additional_accession":[]},"is_claimable":false,"name":"KASL clinical practice guidelines for management of autoimmune hepatitis 2022.","description":null,"dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Jul","modification":"2025-04-22T13:32:35.378Z","creation":"2025-04-06T00:41:24.935Z"},"accession":"S-EPMC10366804","cross_references":{"pubmed":["37137334"],"doi":["10.3350/cmh.2023.0087"]}}